Fisher & Paykel boss Lewis Gradon gets hefty pay boost after hitting targets

Fisher & Paykel boss Lewis Gradon gets hefty pay boost after hitting targets
Fisher & Paykel Healthcare and its managing director Lewis Gradon hit targets for operating revenue, profit and cashflow. (Image: NZME)
Rebecca Stevenson
New Zealand Exchange-listed medical device manufacturer Fisher & Paykel Healthcare says the feedback from US customers on its new solo mask for obstructive sleep apnea has been tremendous. Fisher & Paykel reported its full-year result to March 31 on Wednesday, reporting underlying net profit after tax of $264.4 million after stripping out one-off items including a $98m revaluation of land it purchased at Karaka. Free cashflow rose to $73.8m compared to $12.5m in the previous financial year, while operating revenue wa...

More Markets

NZ sharemarket up 0.4% despite inflation report
Markets Market Close

NZ sharemarket up 0.4% despite inflation report

The S&P/NZX 50 Index closed at 13,344.96, up 55.75 points or 0.42%.

What Infratil likes about Contact Energy
Infrastructure

What Infratil likes about Contact Energy

Infratil is keeping its options open, while TECT diversifies.

Disclosure breaches Class action against ANZ NZ continues
Finance

Disclosure breaches Class action against ANZ NZ continues

It comes as retrospective law tweaks fail to give relief.

Kiwi Capital Limited appoints Susan Peterson as chair
Finance

Kiwi Capital Limited appoints Susan Peterson as chair

New chair of Kiwibank parent company Kiwi Capital Ltd brings breadth of experience.